It is suggested that overlapping of HBV infection and/or disorder of immune system may help and accelerate the development of anti GOR induced by HCV infection in patients with PHC.

• 表明GOR抗体的出现与HCV感染密切相关，而与HBV感染或肝癌本身无关，在HCV和HBV血清标志均阳性的肝癌患者中，GOR抗体阳性率高达87.；5%25，提示HBV重叠感染和（或）肝癌患者免疫功能紊乱可协助、促进HCV感染诱导的GOR抗体的产生。